Zymogen inhibition

pathway activity — cross-omics
GO:0097341Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Zymogen inhibition pathway is significantly associated with the RNA expression of multiple genes, with the UCEC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are DEPDC1, MPP1, and LGALS3, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile.

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECDEPDC1 →-0.796-0.895<.001.00136
GBMMPP1 →+0.395+0.339.001<.00135
CCRCCLGALS3 →+0.510+0.230.002.00235
LSCCIL18 →+0.922+0.802<.001<.00135
GBMGAREM2 →-1.014-0.407<.001<.00135
GBMCD59 →+0.430+0.317<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

Exploration